BioFactura, Inc.
High-value biosimilars, biodefense medical countermeasures, and novel drugs manufactured through biologics production
- Sector
- Biotech
- Headquarters
- FREDERICK, MD
- Latest Form D
- $1.8M, May 2016
- Total capital
- $1.8M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $1.8M
- 1 Form D · last May 2016
- 126 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 1
- 7 pending · first 2020
- Rank in peer group#481 of 1449
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 1st filing$1.8M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 1449 peers
Line = medianBiotech · Molecule
- Granted patents#481 · top 33%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Darryl SampeyExecutive Officer, DirectorNamed in SEC Form D filings
- Jeffrey N Hausfeld, MDExecutive Officer, DirectorNamed in SEC Form D filings
What it has protected
USPTO · 1 granted of 8- PendingCompositions and Methods for the Prevention and Treatment of Orthopoxvirus InfectionsUSPTOApplication 19064808
- GrantedMethods Of Manufacturing Therapeutic ProteinsUSPTOUS 10,774,353
- PendingCompositions and Methods for the Prevention and Treatment of Orthopoxvirus InfectionsUSPTOApplication 63402900
Show all 8 patent records
- Compositions and Methods for the Prevention and Treatment of Orthopoxvirus InfectionsMar 5, 2026 · Application 19064808Pending
- Methods Of Manufacturing Therapeutic ProteinsSep 15, 2020 · US 10,774,353Granted
- Compositions and Methods for the Prevention and Treatment of Orthopoxvirus InfectionsApplication 63402900Pending
- Methods Of Manufacturing Therapeutic ProteinsApplication PCTUS2016029472Pending
- Methods Of Manufacturing Therapeutic ProteinsApplication 62153178Pending
- Separation Of Antigen-specific Memory B Cells With A Conjugated Biopolymer SurfaceApplication PCTUS2010026624Pending
- Compositions And Methods For Metabolic Selection Of Transfected CellsApplication PCTUS2006019344Pending
- Compositions And Methods For The Prevention And Treatment Of Orthopoxvirus InfectionsApplication PCTUS2023031646Pending
Related companies, and why
- Rhinal Therapeutics Inc.Similar federal contract value in Biotech · null in contracts
- Porosome Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
- CRISPRQC INC.Similar federal contract value in Biotech · null in contracts
- PNP THERAPEUTICS INCSimilar federal contract value in Biotech · null in contracts
- Nu-Tek BioSciences, LLCSimilar federal contract value in Biotech · null in contracts
- CORE ONE LABS INC.Similar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .